M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Coronary artery bypass grafting-fifty years of quality initiatives since Favaloro.
John J. Squiers,Michael J. Mack +1 more
TL;DR: Some of the key developments in CABG over the last 50 years are reviewed with a focus on ongoing quality initiatives that will continue to refine the optimal applications and outcomes of CABGs for the next 50 years.
Journal ArticleDOI
Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience.
John G. Webb,Anthony Chuang,David Meier,Ralph Stephan von Bardeleben,Susheel Kodali,Robert Smith,Jörg Hausleiter,Geraldine Ong,Robert H. Boone,Tobias Ruf,Isaac George,Molly Szerlip,Michael Näbauer,Faeez M. Ali,Robert Moss,Felix Kreidel,Vinayak Bapat,Katharina Schnitzler,Jian Ye,Mirjam G. Wild,Mariama Akodad,Djeven P. Deva,Andrew Chatfield,Michael J. Mack,Paul A. Grayburn,Mark D. Peterson,Raj Makkar,Martin B. Leon,Rebecca T. Hahn,Neil Fam +29 more
TL;DR: The first-in-human experience with the transfemoral transcatheter EVOQUE tricuspid valve replacement system reported favorable 30-day outcomes with no mortality in a compassionate use population as mentioned in this paper .
Journal ArticleDOI
Impact of short-term complications of transcatheter aortic valve replacement on longer-term outcomes: results from the STS/ACC Transcatheter Valve Therapy Registry.
Suzanne V. Arnold,Pratik Manandhar,Sreekanth Vemulapalli,Andrzej S. Kosinski,Nimesh D. Desai,Joseph E. Bavaria,John D. Carroll,Michael J. Mack,Vinod H. Thourani,David J. Cohen +9 more
TL;DR: It is found that complications remain common within the first 30 days after TAVR and are associated with worse one-year survival and health status among survivors, which support continued efforts to reduce major complications of T AVR and may also help define quality of care.
Journal ArticleDOI
Uncertainty and Possible Subclinical Valve Leaflet Thrombosis
David R. Holmes,Michael J. Mack +1 more
TL;DR: Transcatheter aortic-valve replacement (TAVR) has had a profound effect on the management of structural heart disease, as evidenced by the fact that since 2010 the Journal has featured six reports on pivotal registries or randomized TAVR trials.
Journal ArticleDOI
Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.
Brian R. Lindman,Devraj Sukul,Marc R. Dweck,Mahesh V. Madhavan,Benoit J. Arsenault,Megan Coylewright,W. David Merryman,David E. Newby,John Lewis,Frank E. Harrell,Michael J. Mack,Martin B. Leon,Catherine M Otto,Philippe Pibarot +13 more
TL;DR: In this article, a review briefly discusses the pathobiology and most promising pharmacologic targets, screening, diagnosis and progression of calcific aortic stenosis, identification of subgroups that should be targeted in clinical trials, and the need to elicit the patient voice earlier rather than later in clinical trial design and implementation.